CARLEVENT levodopa/carbidopa/entacapone 100/25/200 mg tablet bottle Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

carlevent levodopa/carbidopa/entacapone 100/25/200 mg tablet bottle

medis pharma pty ltd - entacapone, quantity: 200 mg; levodopa, quantity: 100 mg; carbidopa monohydrate, quantity: 27 mg (equivalent: carbidopa, qty 25 mg) - tablet, film coated - excipient ingredients: sodium sulfate; powdered cellulose; hyprolose; trehalose dihydrate; magnesium stearate; carmellose sodium; microcrystalline cellulose; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; lecithin - levodopa/carbidopa/entacapone is indicated for the management of patients with parkinson?s disease who are experiencing motor fluctuations.

CARLEVENT levodopa/carbidopa/entacapone 50/12.5/200 mg tablet bottle Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

carlevent levodopa/carbidopa/entacapone 50/12.5/200 mg tablet bottle

medis pharma pty ltd - entacapone, quantity: 200 mg; levodopa, quantity: 50 mg; carbidopa monohydrate, quantity: 13.5 mg (equivalent: carbidopa, qty 12.5 mg) - tablet, film coated - excipient ingredients: sodium sulfate; powdered cellulose; magnesium stearate; carmellose sodium; microcrystalline cellulose; trehalose dihydrate; hyprolose; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; lecithin - levodopa/carbidopa/entacapone is indicated for the management of patients with parkinson?s disease who are experiencing motor fluctuations.

Madopar Namībija - angļu - Namibia Medicines Regulatory Council

madopar

roche products (pty) ltd - benserazide hydrochloride ; ; levodopa - tablet - each tablet contains ; benserazide hydrochloride equivalent to 50mg benserazide ; levodopa 200mg

PROLOPA CAP 100-25 CAPSULE Kanāda - angļu - Health Canada

prolopa cap 100-25 capsule

hoffmann-la roche limited - levodopa; benserazide (benserazide hydrochloride) - capsule - 100mg; 25mg - levodopa 100mg; benserazide (benserazide hydrochloride) 25mg - dopamine precursors

PROLOPA CAP 200-50 CAPSULE Kanāda - angļu - Health Canada

prolopa cap 200-50 capsule

hoffmann-la roche limited - levodopa; benserazide (benserazide hydrochloride) - capsule - 200mg; 50mg - levodopa 200mg; benserazide (benserazide hydrochloride) 50mg - dopamine precursors

PROLOPA CAP 50-12.5 CAPSULE Kanāda - angļu - Health Canada

prolopa cap 50-12.5 capsule

hoffmann-la roche limited - levodopa; benserazide (benserazide hydrochloride) - capsule - 50mg; 12.5mg - levodopa 50mg; benserazide (benserazide hydrochloride) 12.5mg - dopamine precursors

STALEVO 125/31.25/200 levodopa/carbidopa (as monohydrate)/entacapone  tablet bottle Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

stalevo 125/31.25/200 levodopa/carbidopa (as monohydrate)/entacapone tablet bottle

sandoz pty ltd - levodopa, quantity: 125 mg; entacapone, quantity: 200 mg; carbidopa monohydrate, quantity: 33.8 mg (equivalent: carbidopa, qty 31.25 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; magnesium stearate; maize starch; mannitol; povidone; glycerol; hypromellose; polysorbate 80; iron oxide red; sucrose; titanium dioxide - stalevo is indicated for the management of patients with parkinson's disease who are experiencing motor fluctuations.

STALEVO 75/18.75/200 levodopa/carbidopa (as monohydrate)/entacapone tablet bottle Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

stalevo 75/18.75/200 levodopa/carbidopa (as monohydrate)/entacapone tablet bottle

sandoz pty ltd - levodopa, quantity: 75 mg; entacapone, quantity: 200 mg; carbidopa monohydrate, quantity: 20.25 mg (equivalent: carbidopa, qty 18.75 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; magnesium stearate; maize starch; mannitol; povidone; glycerol; hypromellose; polysorbate 80; iron oxide red; sucrose; titanium dioxide - stalevo is indicated for the management of patients with parkinson's disease who are experiencing motor fluctuations.

STALEVO 200/50/200 levodopa/carbidopa (as monohydrate)/entacapone tablet bottle Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

stalevo 200/50/200 levodopa/carbidopa (as monohydrate)/entacapone tablet bottle

sandoz pty ltd - levodopa, quantity: 200 mg; entacapone, quantity: 200 mg; carbidopa monohydrate, quantity: 54.1 mg (equivalent: carbidopa, qty 50 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; magnesium stearate; maize starch; mannitol; povidone; glycerol; hypromellose; polysorbate 80; iron oxide red; sucrose; titanium dioxide - stalevo is indicated for the management of patients with parkinson's disease who are experiencing motor fluctuations.